Federated Hermes
MGNX icon

Federated Hermes’s MacroGenics MGNX Stock Holding History

Federated Hermes’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,091
Closed -$9.01K – 2143
2025
Q1 		$9.01K Buy
+7,091
New +$18.5K ﹤0.01% 1821
2024
Q3 		– Sell
-300,499
Closed -$1.28M – 2121
2024
Q2 		$1.28M Sell
300,499
-153,233
-34% -$1.49M ﹤0.01% 1030
2024
Q1 		$6.68M Sell
453,732
-349,643
-44% -$5.28M 0.02% 657
2023
Q4 		$7.73M Sell
803,375
-126,701
-14% -$876K 0.02% 618
2023
Q3 		$4.33M Sell
930,076
-11,086
-1% -$55.2K 0.01% 734
2023
Q2 		$5.04M Sell
941,162
-14,730
-2% -$90.9K 0.01% 692
2023
Q1 		$6.85M Sell
955,892
-40,090
-4% -$241K 0.02% 631
2022
Q4 		$6.68M Sell
995,982
-414,617
-29% -$2.27M 0.02% 624
2022
Q3 		$4.88M Buy
1,410,599
+303,053
+27% +$1.16M 0.01% 678
2022
Q2 		$3.27M Buy
1,107,546
+817,088
+281% +$4.29M 0.01% 802
2022
Q1 		$2.56M Buy
+290,458
New +$3.21M 0.01% 966
2021
Q2 		– Sell
-963
Closed -$31K – 2281
2021
Q1 		$31K Buy
963
+531
+123% +$12.9K ﹤0.01% 1913
2020
Q4 		$10K Sell
432
-7,834
-95% -$180K ﹤0.01% 1986
2020
Q3 		$209K Buy
8,266
+4,120
+99% +$112K ﹤0.01% 1646
2020
Q2 		$116K Sell
4,146
-12,324
-75% -$214K ﹤0.01% 1690
2020
Q1 		$96K Sell
16,470
-1,989
-11% -$18.1K ﹤0.01% 1653
2019
Q4 		$201K Sell
18,459
-944,383
-98% -$9.35M ﹤0.01% 1602
2019
Q3 		$12.3M Buy
962,842
+113,035
+13% +$1.63M 0.03% 505
2019
Q2 		$14.4M Sell
849,807
-250,881
-23% -$4.31M 0.04% 452
2019
Q1 		$19.8M Buy
1,100,688
+1,100,155
+206,408% +$19M 0.05% 347
2018
Q4 		$7K Sell
533
-57
-10% -$956 ﹤0.01% 1923
2018
Q3 		$13K Sell
590
-94
-14% -$2K ﹤0.01% 1909
2018
Q2 		$14K Sell
684
-3,089
-82% -$69.6K ﹤0.01% 1860
2018
Q1 		$95K Buy
3,773
+2,995
+385% +$72.7K ﹤0.01% 1600
2017
Q4 		$15K Buy
778
+201
+35% +$3.75K ﹤0.01% 1819
2017
Q3 		$11K Sell
577
-37
-6% -$641 ﹤0.01% 1832
2017
Q2 		$11K Buy
614
+20
+3% +$381 ﹤0.01% 1822
2017
Q1 		$11K Sell
594
-190,298
-100% -$3.67M ﹤0.01% 1805
2016
Q4 		$3.9M Sell
190,892
-67,084
-26% -$1.69M 0.01% 627
2016
Q3 		$7.72M Sell
257,976
-441,524
-63% -$13.1M 0.02% 481
2016
Q2 		$18.9M Hold
699,500
– – 0.06% 279
2016
Q1 		$13.1M Hold
699,500
– – 0.04% 370
2015
Q4 		$21.7M Sell
699,500
-178,160
-20% -$5.41M 0.07% 266
2015
Q3 		$18.8M Buy
877,660
+221,172
+34% +$6.94M 0.06% 297
2015
Q2 		$24.9M Buy
656,488
+4,588
+0.7% +$151K 0.07% 277
2015
Q1 		$20.4M Buy
651,900
+504,200
+341% +$17.1M 0.06% 298
2014
Q4 		$5.18M Sell
147,700
-145,200
-50% -$3.62M 0.02% 601
2014
Q3 		$6.12M Buy
292,900
+15,700
+6% +$325K 0.02% 575
2014
Q2 		$6.02M Buy
277,200
+162,600
+142% +$3.42M 0.02% 598
2014
Q1 		$3.19M Hold
114,600
– – 0.01% 785
2013
Q4 		$3.14M Buy
+114,600
New +$3M 0.01% 772

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Federated Hermes's MGNX Position: Q2 2025 in Review

Federated Hermes sold out of MacroGenics (MGNX) in Q2 2025, closing a stake of 7,091 shares — an estimated $9.01K sold.

Federated Hermes first reported a position in MGNX in Q4 2013 and held it in 41 quarters. The position peaked at $24.9M in Q2 2015. 112 funds tracked by Wall St. Rank hold MGNX as of Q2 2025.

  • Federated Hermes reported no remaining MacroGenics position as of Q2 2025 after selling out during the quarter.
  • Federated Hermes sold 7,091 MacroGenics shares in Q2 2025, an estimated $9.01K.
  • Federated Hermes first reported a position in MacroGenics in Q4 2013 and held it in 41 quarters.
  • Federated Hermes's MacroGenics position peaked at $24.9M in Q2 2015.
  • 112 funds tracked by Wall St. Rank held MacroGenics as of Q2 2025.

Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.